Waltham, MA – Nova Biomedical today announced a collaboration with Sartorius Stedim Biotech (SSB) for integration of the Nova BioProfile FLEX2 comprehensive cell culture chemistry analyzer with the ambr microbioreactor system. Under the terms of the agreement, technical experts from Nova and SSB collaborated to combine the cell culture analysis capabilities of the BioProfile FLEX2 with the automated sampling functions and control software of the ambr® 15 cell culture system... Details

Waltham, MA – Nova Biomedical is pleased to announce the opening of a new sales, service, manufacturing, and distribution subsidiary in Brazil. The new facility demonstrates Nova’s commitment to the Brazilian market and to supporting the strong growth of in vitro diagnostic testing in Brazil and Mercosur countries... Details

Waltham, MA – On January 27, 2016, the Food and Drug Administration (FDA) cleared Nova’s StatStrip Glucose Xpress 2 Hospital Meter System for use throughout all professional healthcare settings, including with critically ill patients... Details

Waltham, MA – On May 20, 2015, the U.S. Food and Drug Administration (FDA) cleared Nova Biomedical’s StatStrip Xpress Glucose Hospital Meter System for use throughout all hospital and all professional healthcare settings, including critically ill patients. Details

Only glucose monitoring system FDA-cleared for use throughout all hospital settings, all professional healthcare settings, and all patient populations including critical care FOR IMMEDIATE RELEASE: September 25, 2014 Contact: Ron Newby, Director of Marketing Phone: (781) 894-0800 Waltham, MA – Nova Biomedical’s StatStrip Glucose Hospital Meter System is the first blood glucose monitoring… Details

Waltham, MA (February 2nd, 2014) The Nova Scholarships were started in 1989. The Scholarship program includes two distinct scholarship funds:
The Thomas Gross Scholarships, established in 1989, and the Frederick Spaziani Scholarship, established in 1992. Since the first Scholarship Awards in 1990,
Nova has given a total of $1,899,000 in scholarships and awards. Details

ABSTRACT: Current initiatives within the biopharmaceutical industry to adopt PAT (Process Analytical Technology) approaches in manufacturing, include activities in
early process development. With adherent cell lines, online sampling for real‐time process monitoring and process adjustment is challenging due to the viscosity of the
cell culture and potential blockages to sampling systems caused by microcarriers. Details

Waltham, MA (February 2nd, 2014) The Nova Scholarships were started in 1989. The Scholarship program includes two distinct scholarship funds:
The Thomas Gross Scholarships, established in 1989, and the Frederick Spaziani Scholarship, established in 1992. Since the first Scholarship Awards in 1990,
Nova has given a total of $1,899,000 in scholarships and awards. Details

Objectives: The aims of this study were to: (1) determine the validity and reliability of the Nova Biomedical Lactate Plus portable analyzer, and quantify any fixed or proportional bias; (2) determine the effect of any bias on the determination of the lactate threshold and (3) determine the effect that blood sampling methods have on validity… Details

Waltham, MA (September 22, 2011) – Nova Max® Plus proved to be more accurate than other leading brand self-monitoring blood glucose meters (SMBG) in a study presented September 14th, 2011 at the European Association for the Study of Diabetes (EASD). The study was performed by the Clinical Translational Research and Innovation Center, University of Ulster,… Details

On April 28, 2011, United States Senator Scott Brown (R. MA) visited Nova Biomedical, the largest privately held in vitro diagnostic company in the U.S. and one of the largest employers among Massachusetts medical device companies. During his visit, Senator Brown toured Nova’s 300,000 square foot manufacturing, research and development facility in Waltham, Massachusetts, and… Details

On January 14, 2011, LifeScan announced they were withdrawing from the hospital point-of-care glucose testing market in North America. The announcement provided LifeScan users with a brief, 26-month period to identify, evaluate, and implement a new partner. Nova Biomedical is prepared to help you begin now to transition to a new POC glucose partner to… Details

On July 27, 2010 The Honorable Joseph J. Farnan of the United States District Court for the District of Delaware issued an order granting client Nova Biomedical Corporation’s motion for summary judgment of non-infringement of two patents asserted by Roche Diagnostics Operations Inc. and Corange Int’l Ltd. The Court’s order is based on the September… Details

Waltham, MA. January 2010 – Nova Biomedical announced it has been awarded a new multi-year glucose monitoring system agreement with Premier Purchasing Partners, the group purchasing unit of Premier, Inc. This new agreement provides Premier members access to contracts for Nova’s lab-accurate and interference-free StatStrip® Glucose technology for monitoring glucose levels in hospital patients. The… Details

Waltham, MA. – Nova Biomedical’s StatStrip® Xpress™ glucose monitor has been granted CLIA-waived status from the U.S. Food and Drug Administration. StatStrip Xpress is Nova’s non-connectivity companion meter to the CLIA-waived StatStrip Hospital Glucose Meter. StatStrip Xpress can now be operated under a certificate of waiver in point-of-care settings such as ambulances and remote non-hospital locations that do not require the network capabilities of the StatStrip Hospital Glucose Meter.… Details

If You Are Not Using Nova’s Glucose StatStrip, You Are Misdosing Dependent Patients Who Have Abnormal Hematocrits According to a recent published study1 by the Mayo Clinic, only Nova’s StatStrip continued to give accurate glucose results as patient hematocrits varied from 20% – 65%. Hematocrit related errors of 20% to nearly 50% were reported on… Details

Nova’s new StatStrip™ Glucose Monitor has received clearance from the U.S. Food and Drug Administration for use in neonatal testing. Severe hematocrit abnormalities are routinely found in neonates. Other glucose monitors may report an error if the hematocrit value is abnormal, StatStrip is the only glucose monitor that measures hematocrit on the strip, automatically correcting…Details

An advanced blood glucose monitoring system from Nova Biomedical provides a fast, convenient solution for diabetes self-testing. The newly released Nova Max™ system is built around patented* new technology test strips that are so precise they do not require the calibration or coding required of currently available blood glucose monitors to perform a glucose test…. Details

Nova Biomedical announces the incorporation of total bilirubin (tBil) to the comprehensive test menu on its StatProfile® Critical Care Xpress (CCX) “All-in-One” Analyzers. Bilirubin is an important indicator of liver function. Its intended use is for the adult population, and neonatal patients to be cleared soon. With the addition of total bilirubin, the CCX analyzer…Details

An advanced blood glucose monitoring system from Nova Biomedical elevates bedside glucose testing to a new level of analytical performance that approaches the quality of central laboratory testing. The Nova StatStrip™ point-of-care glucose monitor incorporates a patented* new strip technology that uses four measuring wells. Current glucose strips use only one well. Nova’s Multi-Well™ system…Details

Nova Biomedical is pleased to announce an extension of its contract to provide multi-analyte point-of-care testing instrumentation to Novation through July 31, 2009. Under the terms of the agreement, Nova Biomedical will provide our advanced series of StatProfile® Critical Care Xpress (CCX) analyzers, reagents, and consumables, and our service contracts to Novation members, associates, and… Details

A new Connectivity Suite from Nova Biomedical is a complete plug and play solution for use with the BioProfile® FLEX Cell Culture Analyzer that facilitates Nova’s groundbreaking bi-directional automation and product integration. The BioProfile FLEX Connectivity Suite features complete connectivity with all OPC-compliant systems including bioreactor controllers, data historians, overall IT infrastructure, and plant manager…Details